Travere Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 02/17/2026 | 10.51 M | $401.72 M | -0.83% | 11.78% |
| FMR LLC | 02/17/2026 | 9.62 M | $367.50 M | 232.32% | 10.78% |
| BLACKROCK, INC. | 02/12/2026 | 7.87 M | $300.69 M | -2.85% | 8.82% |
| VANGUARD GROUP INC | 01/29/2026 | 6.31 M | $241.08 M | -4.60% | 7.07% |
| STATE STREET CORP | 02/13/2026 | 4.76 M | $181.75 M | 47.82% | 5.33% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 4.28 M | $163.47 M | 12.74% | 4.79% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 3.77 M | $144.19 M | 100.00% | 4.23% |
| ARMISTICE CAPITAL, LLC | 02/17/2026 | 3.76 M | $143.82 M | -44.02% | 4.22% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 2.93 M | $111.84 M | -17.60% | 3.28% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 2.25 M | $85.85 M | 28.23% | 2.52% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 2.21 M | $84.46 M | 2.10% | 2.48% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 2.14 M | $81.92 M | 0.26% | 2.40% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.87 M | $71.38 M | 46.65% | 2.09% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 1.85 M | $70.70 M | 32.27% | 2.07% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 02/05/2026 | 1.72 M | $65.78 M | 7.62% | 1.93% |
| EMERALD ADVISERS, LLC | 02/09/2026 | 1.59 M | $60.91 M | -25.74% | 1.79% |
| MORGAN STANLEY | 02/13/2026 | 1.42 M | $54.10 M | 26.75% | 1.59% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 1.17 M | $44.90 M | -17.09% | 1.32% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.16 M | $44.20 M | 24.52% | 1.30% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.09 M | $41.82 M | 65.03% | 1.23% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 1.02 M | $38.91 M | 100.00% | 1.14% |
| NUVEEN, LLC | 02/12/2026 | 993.61 K | $37.97 M | -7.89% | 1.11% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 02/09/2026 | 948.46 K | $36.24 M | -21.02% | 1.06% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/17/2026 | 901.40 K | $34.44 M | 27.41% | 1.01% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 02/13/2026 | 900.30 K | $34.40 M | 184.63% | 1.01% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 881.68 K | $33.69 M | -44.87% | 0.99% |
| FIERA CAPITAL CORP | 02/11/2026 | 874.05 K | $33.40 M | 100.00% | 0.98% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/17/2026 | 867.62 K | $33.15 M | -1.82% | 0.97% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 808.19 K | $30.88 M | -4.73% | 0.91% |
| ENSIGN PEAK ADVISORS, INC | 02/12/2026 | 805.22 K | $30.77 M | -5.51% | 0.90% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 798.98 K | $30.53 M | -33.50% | 0.90% |
| NORTHERN TRUST CORP | 02/17/2026 | 761.47 K | $29.10 M | -8.49% | 0.85% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 725.50 K | $27.72 M | 4.13% | 0.81% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 718.40 K | $27.45 M | 70.88% | 0.81% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 700.00 K | $26.75 M | 0.00% | 0.78% |
| CAPTION MANAGEMENT, LLC | 02/17/2026 | 666.40 K | $25.46 M | 15.82% | 0.75% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 665.80 K | $25.44 M | 17.72% | 0.75% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2026 | 623.39 K | $23.82 M | -27.34% | 0.70% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2026 | 587.35 K | $22.44 M | 3.10% | 0.66% |
| LEGAL & GENERAL GROUP PLC | 02/09/2026 | 536.93 K | $20.52 M | 3.14% | 0.60% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 534.61 K | $20.78 M | -21.88% | 0.60% |
| ABRDN PLC | 01/16/2026 | 518.36 K | $19.81 M | -46.42% | 0.58% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 517.88 K | $19.79 M | -45.47% | 0.58% |
| INVESCO LTD. | 02/19/2026 | 474.08 K | $18.11 M | -24.50% | 0.53% |
| CANDRIAM S.C.A. | 04/30/2026 | 468.56 K | $17.90 M | -8.61% | 0.53% |
| UBS GROUP AG | 01/29/2026 | 422.62 K | $16.15 M | -14.29% | 0.47% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/09/2026 | 417.74 K | $15.96 M | 347.48% | 0.47% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 406.22 K | $15.52 M | -28.98% | 0.46% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 394.84 K | $15.09 M | 397.01% | 0.44% |
| JANE STREET GROUP, LLC | 02/12/2026 | 392.27 K | $14.99 M | 100.00% | 0.44% |
Travere Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 348 institutional investors and hedge funds held shares of Travere Therapeutics Inc. The most heavily invested institutionals were:
Stephens Investment Management Group LLC: 1.8 M
EMERALD ADVISERS, LLC: 1.56 M
EMERALD MUTUAL FUND ADVISERS TRUST: 945,033
Nuveen, LLC: 938,569
UBS Group AG: 856,757
abrdn plc: 557,147
114.53% of Travere Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 117.98 M shares in the last 24 months. This purchase volume represents approximately $3.42 B in transactions.